Oral anticoagulant therapy for older patients with atrial fibrillation
Submitted: 1 September 2017
Accepted: 14 September 2017
Published: 29 September 2017
Accepted: 14 September 2017
Abstract Views: 1361
PDF: 742
HTML: 434
HTML: 434
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Francesco Vetta, Gabriella Locorotondo, Giampaolo Vetta, Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword , Geriatric Care: Vol. 3 No. 2 (2017)
- Mario Bo, Yolanda Falcone, Enrica Grisoglio, Margherita Marchetti, Federica Li Puma, Marina Iacovino, Enrico Brunetti, Gianfranco Fonte, Antiplatelet therapy is not a safer alternative to oral anticoagulants, even in older hospital-discharged patients with atrial fibrillation , Geriatric Care: Vol. 2 No. 2 (2016)
- Antonio Cherubini, Barbara Carrieri, Paolo Marinelli, Advantages and disadvantages of direct oral anticoagulants in older patients , Geriatric Care: Vol. 4 No. 1 (2018)
- Angelo Di Salvo, The role of association between the cholinergic precursor choline alphoscerate and sulodexide in vascular dementia , Geriatric Care: Vol. 7 No. 3 (2021)
You may also start an advanced similarity search for this article.